COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
- PMID: 32247518
- PMCID: PMC7270810
- DOI: 10.1016/j.ajo.2020.03.028
COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
References
-
- Gao J., Zhenxue T., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72–73. - PubMed
-
- Marmor M., Kellner U., Lai T.Y., Melles R.B., Mieler W.F. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision) Ophthalmology. 2016;123(6):1386–1394. - PubMed
-
- Furst D.E., Lindsley H., Baethge B., et al. Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension. Arthritis Rheum. 1999;42(2):357–365. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
